Skip to main content
PALTC24 - AMDA Annual Conference Main banner
Purchase conference recordings
Purchase 2024 conference recordings
Back
Evaluation

Innovation in PALTC

(MO13) Building a Culture to Support Appropriate Prescribing of Antipsychotics in Long-Term Care

Monday, March 11, 2024
2:00 PM – 3:00 PM CT
Room: Stars at Night Ballroom B1
CMD Management Credit Recording
CME: (1) MOC: (1) CMD Management: (1) NP Pharmacology Hours ()

    Session Chair/Speaker(s)

  • Ahmed Vanker, MD

    Physician Assistant
    Extendicare
    Mississauga, ON, Canada

    Disclosure(s): No financial relationships to disclose.

Disclosure(s):
Ahmed Vanker, MD: No financial relationships to disclose.
This session will focus on the implementation of a quality improvement program that significantly reduced the inappropriate use of antipsychotics across Extendicare’s 34 owned homes in Ontario, Canada. The session will describe the development and implementation of an evidence based clinical program to safely reduce or stop antipsychotics for eligible individuals. It will focus on how 2 corporate resource teams – a core clinical team and a core data and analytics team – were utilized to provide training, ongoing support, and analytics to the individual home teams. Finally, the session will highlight the development of a decision support tool that enables the home team to view relevant information by resident and easily track their plan for all residents on Antipsychotics in one place.

Learning Objectives:

At the completion of this session, learners will be able to:
  • Implement an evidence-based program to identify candidates for antipsychotic reduction. They will learn how to use specific clinical assessments to determine who might be a candidate for deprescribing as well as how to safely design tapering regimes.
  • Learn strategies for how to deliver relevant information to clinicians and decision-makers and will learn how to integrate data to create impactful decision support tools. They will hear examples from several homes about how these tools supported the implementation of the antipsychotic QI project and enabled the care teams to more efficiently identify candidates and track progress.
  • Learn how to engage the entire care team in this process. Examples include: engaging physicians so that they support the goals and process; educating front-line staff to identify opportunities for non-pharmacological interventions for behavioural symptoms; and providing family education as they are often concerned about relapsing behaviours.